Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

These medications typically help you control your appetite or help your body respond to the foods you eat. However, these ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being ... “We found that long-term ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

美国俄勒冈州一家医疗中心因前员工涉嫌在手术中将芬太尼静脉注射液替换为自来水，引发至少18名患者细菌感染并导致死亡，目前面临3.03亿美元 （约合人民币21亿元） 的赔偿诉讼。诉讼文件称，该医院未能有效监管一名有药物滥用倾向的前护士。

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

By week 56, kids, ages 6 to <12 years, on once-daily 3-mg liraglutide lost 5.8% of BMI compared with a 1.6% gain with ...